The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...
"With our new AI-native clinical encounter, we're ushering in a new era where technology fades into the background. It listens to the visit, understands the context, and engages in real time ? so ...
Big Four firm KPMG said that young consultants spend too much time on slide decks and need to be more involved in strategic decisions.
UST, a leading AI and technology transformation solutions company, has strengthened its presence at the intersection of human-AI interaction with its recent investment in aiOla. Israel-based aiOla is ...
Standard Chartered has historically operated with laser focus on specific geographic areas and an enthusiasm for linking east ...